Skip to content
EDIVRO

News built for discoveryGEO · AEO · Agentic search

What is Edivro?Sign inSubmit news / Build profile
News

Explore Edivro

The business of what’s next.

News, company developments and ideas from across the Edivro publishing network.

Explore all stories

The front page

  • Latest storiesThe complete publication bank
  • Company news
  • Latest insights
  • Leadership news

Discover more

  • AI & innovation
  • People & profiles
  • Company features
  • Explore all topics
Stories. Connected.

Explore the Edivro story bank.

Explore all stories →
Explore the story bank →
What is Edivro?Editorial standards
Companies

Explore Edivro

Inside the businesses.

Company stories, brand profiles and announcements, with original dates and source attribution.

Explore company news

Companies & brands

  • Company news
  • Company features
  • Brand stories
  • Brand strategy

Explore business

  • Industry coverage
  • Leadership profiles
  • Business insights
  • Browse by location
Stories. Connected.

Explore the Edivro story bank.

Explore company news →
Explore the story bank →
What is Edivro?Editorial standards
Leaders & Profiles

Explore Edivro

The people behind the story.

Meet founders, executives and professionals through their work and published profiles.

Explore leader profiles

People to know

  • Featured leaders
  • Leadership stories
  • Young entrepreneurs
  • Newsmakers

Ideas & work

  • Leadership news
  • Workplace & culture
  • Company stories
  • Browse public profilesPeople behind the coverage
Stories. Connected.

Explore the Edivro story bank.

Explore leader profiles →
Explore the story bank →
What is Edivro?Editorial standards
Industries

Explore Edivro

A wider view of business.

Follow developments across sectors, from artificial intelligence to healthcare and real estate.

Explore all industries

Industry coverage

  • Artificial intelligence
  • Business
  • Real estate
  • Healthcare

More sectors

  • Manufacturing
  • Education
  • Fintech
  • All sectors & topics
Stories. Connected.

Explore the Edivro story bank.

Explore all industries →
Explore the story bank →
What is Edivro?Editorial standards
AI & Tech

Explore Edivro

Ideas changing the way we work.

Artificial intelligence, enterprise technology and the businesses building what comes next.

Explore AI coverage

AI & technology

  • Artificial intelligence
  • Technology stories
  • Enterprise AI & SaaS
  • Fintech & payments

News & insight

  • AI news
  • Industry insights
  • Company announcements
  • Research & ideas
Stories. Connected.

Explore the Edivro story bank.

Explore AI coverage →
Explore the story bank →
What is Edivro?Editorial standards
Press Room

Explore Edivro

Announcements. In context.

Find business announcements, company news and clearly labelled press releases.

Explore the Press Room

Read announcements

  • Company news & releasesAnnouncements from named issuers
  • Company news
  • Latest published stories
  • Browse industries

News by subject

  • Funding & investment
  • Appointments
  • Products & launches
  • Partnerships
Stories. Connected.

Explore the Edivro story bank.

Explore the Press Room →
Explore the story bank →
What is Edivro?Editorial standards
Work with Edivro

Create on Edivro

Choose how you work with Edivro.

Publishing for individuals and companies, client orders for agencies, and wider communications programmes for businesses.

Explore the three routes

Who you are

  • Individuals and companiesProfiles, stories and press releases
  • AgenciesPublishing for authorised clients
  • Corporate and businessPR, content, discovery and campaigns
  • Services & pricingCurrent per-article prices

Publishing tools

  • Build your profile
  • Submit your news
  • Edivro AI
  • How publishing works
Your next story.

Work with Edivro

Choose the route that fits your work.

Explore services
Explore the story bank →
What is Edivro?Editorial standards
Latest storiesCompany newsLeader profilesArtificial intelligence

Explore Edivro

News, companies and the people behind them.

News

Explore Edivro

The business of what’s next.

News, company developments and ideas from across the Edivro publishing network.

Explore all stories

The front page

  • Latest storiesThe complete publication bank
  • Company news
  • Latest insights
  • Leadership news

Discover more

  • AI & innovation
  • People & profiles
  • Company features
  • Explore all topics
Stories. Connected.

Explore the Edivro story bank.

Explore all stories →
Explore the story bank →
What is Edivro?Editorial standards
Companies

Explore Edivro

Inside the businesses.

Company stories, brand profiles and announcements, with original dates and source attribution.

Explore company news

Companies & brands

  • Company news
  • Company features
  • Brand stories
  • Brand strategy

Explore business

  • Industry coverage
  • Leadership profiles
  • Business insights
  • Browse by location
Stories. Connected.

Explore the Edivro story bank.

Explore company news →
Explore the story bank →
What is Edivro?Editorial standards
Leaders & Profiles

Explore Edivro

The people behind the story.

Meet founders, executives and professionals through their work and published profiles.

Explore leader profiles

People to know

  • Featured leaders
  • Leadership stories
  • Young entrepreneurs
  • Newsmakers

Ideas & work

  • Leadership news
  • Workplace & culture
  • Company stories
  • Browse public profilesPeople behind the coverage
Stories. Connected.

Explore the Edivro story bank.

Explore leader profiles →
Explore the story bank →
What is Edivro?Editorial standards
Industries

Explore Edivro

A wider view of business.

Follow developments across sectors, from artificial intelligence to healthcare and real estate.

Explore all industries

Industry coverage

  • Artificial intelligence
  • Business
  • Real estate
  • Healthcare

More sectors

  • Manufacturing
  • Education
  • Fintech
  • All sectors & topics
Stories. Connected.

Explore the Edivro story bank.

Explore all industries →
Explore the story bank →
What is Edivro?Editorial standards
AI & Tech

Explore Edivro

Ideas changing the way we work.

Artificial intelligence, enterprise technology and the businesses building what comes next.

Explore AI coverage

AI & technology

  • Artificial intelligence
  • Technology stories
  • Enterprise AI & SaaS
  • Fintech & payments

News & insight

  • AI news
  • Industry insights
  • Company announcements
  • Research & ideas
Stories. Connected.

Explore the Edivro story bank.

Explore AI coverage →
Explore the story bank →
What is Edivro?Editorial standards
Press Room

Explore Edivro

Announcements. In context.

Find business announcements, company news and clearly labelled press releases.

Explore the Press Room

Read announcements

  • Company news & releasesAnnouncements from named issuers
  • Company news
  • Latest published stories
  • Browse industries

News by subject

  • Funding & investment
  • Appointments
  • Products & launches
  • Partnerships
Stories. Connected.

Explore the Edivro story bank.

Explore the Press Room →
Explore the story bank →
What is Edivro?Editorial standards
Work with Edivro

Create on Edivro

Choose how you work with Edivro.

Publishing for individuals and companies, client orders for agencies, and wider communications programmes for businesses.

Explore the three routes

Who you are

  • Individuals and companiesProfiles, stories and press releases
  • AgenciesPublishing for authorised clients
  • Corporate and businessPR, content, discovery and campaigns
  • Services & pricingCurrent per-article prices

Publishing tools

  • Build your profile
  • Submit your news
  • Edivro AI
  • How publishing works
Your next story.

Work with Edivro

Choose the route that fits your work.

Explore services
Explore the story bank →
What is Edivro?Editorial standards

Your publishing workspace

Build a profile. Prepare your story. Manage orders and billing.

Sign in / create account
What is Edivro?How it worksServices & pricing

Search Edivro

Browse full results →
  1. EDIVRO/
  2. Stories
EDIVRO EditorialHealthcare

Biopharma investments reach patients through different development stages

Sanofi’s factory groundbreaking and Mankind’s biotechnology agreement concern distinct assets and timelines.

By Edivro Industry
Global · 27 Oct 2026 · 2 min read
Share story ↓
Add as a Preferred Source on GoogleFind Edivro on Google News
Biopharma investments reach patients through different development stages — Edivro editorial illustration
EDIVROEditorial illustration

Edivro Industry · Analysis based on the primary sources linked in this article.

At a glance

  • Mankind Pharma’s October announcement describes an agreement to invest €48 million for 70% of Armed Cell Therapeutics, a business developing next-generation CAR-T candidates.
  • A pharmaceutical construction project and an investment in research candidates can both be described as expanding future supply. The assets and milestones involved are different, as two October announcements show.

A pharmaceutical construction project and an investment in research candidates can both be described as expanding future supply. The assets and milestones involved are different, as two October announcements show.

What is Sanofi building?

Sanofi’s 19 October release records groundbreaking for a new insulin active-ingredient facility at its Frankfurt BioCampus. Full production is planned for 2032, once fully licensed. The company describes automation and digital technologies planned for the new site.

That is a construction milestone. It does not show that the new factory is already producing insulin or that it has changed present supply in an individual country.

What has Mankind agreed?

Mankind Pharma’s October announcement describes an agreement to invest €48 million for 70% of Armed Cell Therapeutics, a business developing next-generation CAR-T candidates. The investment gives the proposed majority shareholder exposure to a development pipeline, rather than proving that a candidate has become an approved treatment.

Why keep those stages separate?

Factory completion, licensing, clinical development and regulatory authorisation each require their own evidence. An investment announcement cannot answer all of them. Nor do the two releases establish a clinical comparison between insulin and CAR-T therapies, which serve different purposes.

The useful business information is the nature of the asset, the capital commitment where disclosed and the next stated milestone. Patient availability needs subsequent product- and market-specific confirmation.

Questions about this story

These answers summarise the article and refer to its original reporting period.

What is Sanofi building?

That is a construction milestone. It does not show that the new factory is already producing insulin or that it has changed present supply in an individual country.

What has Mankind agreed?

Mankind Pharma’s October announcement describes an agreement to invest €48 million for 70% of Armed Cell Therapeutics, a business developing next-generation CAR-T candidates. The investment gives the proposed majority shareholder exposure to a development pipeline, rather than proving that a candidate has become an approved treatment.

Why keep those stages separate?

The useful business information is the nature of the asset, the capital commitment where disclosed and the next stated milestone. Patient availability needs subsequent product- and market-specific confirmation.

Sources and links

  • sanofi.com — https://www.sanofi.com/en/media-room/press-releases/2026/2026-10-19-10-30-00-3383205
  • mankindpharma.com — https://www.mankindpharma.com/media/press-release/mankind-pharma-to-acquire-majority-stake-in-armed-cell-therapeutics-marking-strategic-entry-into-next-generation-car-t-therapies/
Request a correctionEditorial standards
HealthcareIndustry AnalysisEdivro Daily 2026 10 27Global

Publisher

Edivro Industry

Share this story

LinkedInFacebookXWhatsAppTelegramRedditPinterestThreadsBlueskyEmail

Healthcare

Related stories

Alisha Moopen: Leading the Next Era of Gulf Healthcare — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

founder story

Alisha Moopen: Leading the Next Era of Gulf Healthcare

From expanding hospital networks to digital health, AI-enabled care and a growing Saudi footprint, Alisha Moopen is helping transform Aster DM Healthcare from a traditional provider into a connected healthcare ecosystem for the GCC.

4 Sept 2026

EDIVRO News Profile feature from the imported archive. Original publication dates retained.

Akbar Moideen Thumbay: Building the Next Generation of UAE Healthcare — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

founder story

Akbar Moideen Thumbay: Building the Next Generation of UAE Healthcare

At the intersection of hospitals, medical education, research and patient experience, Akbar Moideen Thumbay is helping shape the next chapter of one of the UAE’s most distinctive healthcare ecosystems.

4 Sept 2026

EDIVRO News Profile feature from the imported archive. Original publication dates retained.

The Leadership Test in Deciding Which Customers to Stop Serving — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

story

The Leadership Test in Deciding Which Customers to Stop Serving

A strategy becomes easier to assess when a company explains which business it will stop pursuing. The difficult work begins with the obligations that remain.

27 Oct 2026

Pulled from WCRC. Original publication date retained.

Original publication dates and source disclosures are retained. New submissions are reviewed before publication.

EDIVRO

Edivro publishes business news, company and leadership profiles, and industry analysis. Our publishing approach combines SEO, GEO and AEO with clear headlines, named sources and useful answers for readers and AI research agents.

Explore publishing on Edivro
Add as a Preferred Source on GoogleFind Edivro on Google News

About Edivro

  • About us
  • How it works
  • Editorial standards
  • Corrections & contact

Publish with Edivro

  • For creators
  • For agencies
  • For businesses
  • Pricing

Learn about discovery

  • Publishing for search and AI
  • SEO vs GEO vs AEO
  • Agentic search
  • Company announcements
  • Search discovery
  • Measure AI visibility

Explore Edivro

  • Latest stories
  • Industries
  • Company profiles
  • Leadership profiles
  • Press Room

© 2026 EDIVRO. All rights reserved.

Sign in / My StudioTerms & refundsPrivacySubscribe via RSS

Press releases are submitted content and are labelled as such.